Suppr超能文献

S-(α-唾液酸基)-(2→9)-O-(α-唾液酸基)-(2→3′)-β-乳糖神经酰胺的合成

Synthesis of an S-(alpha-sialosyl)-(2----9)-O-(alpha-sialosyl)-(2----3')-beta-lactos ylceramide.

作者信息

Hasegawa A, Ogawa H, Ishida H, Kiso M

机构信息

Department of Applied Bioorganic Chemistry, Gifu University, Japan.

出版信息

Carbohydr Res. 1992 Feb 7;224:175-84. doi: 10.1016/0008-6215(92)84103-y.

Abstract

A ganglioside GD3 analog has been synthesized having an N-acetylneuraminic acid (Neu5Ac) residue alpha-thioglycosidically linked to C-9 of the Neu5Ac residue in the ganglioside GM3 structure. Glycosylation of 2-(trimethylsilyl)ethyl O-(6-O-benzoyl-beta-D-galactopyranosyl)-(1----4)-2,6-di-O-benzoyl-beta-D -glucopyranoside with methyl (methyl 5-acetamido-4,7,8-tri-O-acetyl-9-bromo-3,5,9-trideoxy-D-glycero-alpha-D- galacto-2-nonulopyranosid)onate, which was prepared from methyl (methyl 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-2- nonulopyranosid)onate by 8,9-O-isopropylidenation, O-acetylation, hydrolysis of the isopropylidene group, selective bromination, and O-acetylation, using dimethyl(methylthio)sulfonium triflate (DMTST) as a promoter, gave the alpha-sialosyl-(2----3')-lactoside 8. Coupling of the O-acetyl derivative of 8 with the sodium salt of methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-2-thio-D-glycero-alpha-D- galacto-2-nonulopyranosonate gave an alpha-thioglycosidically linked tetrasaccharide. This was converted, via selective removal of the 2-(trimethylsilyl)ethyl group, trichloroacetimidation, and glycosidation with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol into a ganglioside precursor. Finally the precursor on selective reduction of the azide group, coupling with octadecanoic acid, O-deacylation, and de-esterification gave the analog, S-(N-acetyl-alpha-neuraminosyl)-(2----9)-O-(N-acetyl-9-thio-alpha- neuraminosyl)-(2----3')-beta-lactosylceramide.

摘要

已合成一种神经节苷脂GD3类似物,其具有一个N-乙酰神经氨酸(Neu5Ac)残基,该残基通过α-硫糖苷键连接到神经节苷脂GM3结构中Neu5Ac残基的C-9位。用甲基(甲基5-乙酰氨基-4,7,8-三-O-乙酰基-9-溴-3,5,9-三脱氧-D-甘油-α-D-半乳糖-2-壬吡喃糖苷)酸酯对2-(三甲基硅基)乙基O-(6-O-苯甲酰基-β-D-吡喃半乳糖基)-(1→4)-2,6-二-O-苯甲酰基-β-D-吡喃葡萄糖苷进行糖基化反应,该甲基(甲基5-乙酰氨基-4,7,8-三-O-乙酰基-9-溴-3,5,9-三脱氧-D-甘油-α-D-半乳糖-2-壬吡喃糖苷)酸酯是由甲基(甲基5-乙酰氨基-3,5-二脱氧-D-甘油-α-D-半乳糖-2-壬吡喃糖苷)酸酯经8,9-O-异亚丙基化、O-乙酰化、亚异丙基水解、选择性溴化和O-乙酰化制备而成,使用三氟甲磺酸二甲硫鎓(DMTST)作为促进剂,得到α-唾液酸基-(2→3')-乳糖苷8。8的O-乙酰基衍生物与甲基5-乙酰氨基-4,7,8,9-四-O-乙酰基-3,5-二脱氧-2-硫代-D-甘油-α-D-半乳糖-2-壬吡喃糖酸钠盐偶联,得到一个α-硫糖苷键连接的四糖。通过选择性去除2-(三甲基硅基)乙基基团、三氯乙酰亚胺化以及与(2S,3R,4E)-2-叠氮基-3-O-苯甲酰基-4-十八碳烯-1,3-二醇进行糖基化反应,将其转化为神经节苷脂前体。最后,该前体经叠氮基团的选择性还原、与十八烷酸偶联、O-脱酰基化和脱酯化反应,得到类似物S-(N-乙酰-α-神经氨酰基)-(2→9)-O-(N-乙酰-9-硫代-α-神经氨酰基)-(2→3')-β-乳糖基神经酰胺。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验